2022
DOI: 10.3389/fendo.2022.827512
|View full text |Cite
|
Sign up to set email alerts
|

Do Relaxin Levels Impact Hip Injury Incidence in Women? A Scoping Review

Abstract: PurposeThe aim of this review is to assess the current evidence regarding the impact of relaxin on incidence of soft tissue hip injuries in women.MethodsA trained research librarian assisted with searches of PubMed, Embase, CINAHL, and SPORTDiscus, with a preset English language filter. The review was completed per the Joanna Briggs Institute (JBI) Manual for Evidence Synthesis methodology. Included studies required assessment of relaxin effects on musculoskeletal health, pelvic girdle stability, or hip joint … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
4
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 8 publications
(4 citation statements)
references
References 77 publications
0
4
0
Order By: Relevance
“…Although the baseline serum level of relaxin is similar in both sexes, relaxin receptors are only found in the female ACL, putting female athletes at an increased risk of ACL rupture during the time of peak serum levels of relaxin, between days 21 and 24 of the cycle. 7 A higher average serum level of relaxin has been identified in elite female athletes with ACL ruptures compared with those without ruptures. Hence, it can be speculated that an increased serum level of relaxin is a risk factor for sustaining an ACL injury.…”
Section: Endogenous Hormones and The Anterior Cruciate Ligamentmentioning
confidence: 98%
“…Although the baseline serum level of relaxin is similar in both sexes, relaxin receptors are only found in the female ACL, putting female athletes at an increased risk of ACL rupture during the time of peak serum levels of relaxin, between days 21 and 24 of the cycle. 7 A higher average serum level of relaxin has been identified in elite female athletes with ACL ruptures compared with those without ruptures. Hence, it can be speculated that an increased serum level of relaxin is a risk factor for sustaining an ACL injury.…”
Section: Endogenous Hormones and The Anterior Cruciate Ligamentmentioning
confidence: 98%
“… 17 It has also been suggested that hormonal fluctuations in other hormones, such as relaxin, may increase the risk of ACL rupture. 17 , 23 The ACL of female patients has been shown to have concentrations of relaxin receptors, and the levels of relaxin have been shown to peak during the luteal phase of the menstrual cycle. This may increase laxity in the ACL and increase the risk of rupture.…”
Section: Introductionmentioning
confidence: 99%
“…Whilst some studies find greater joint laxity in the ovulatory phase compared to the other two phases [10][11][12], other studies have found no impact of MCP on tendon biomechanical properties [13,14], tendon fibril characteristics, or collagen cross-linking (8). A recent scoping review also describes that not only are menstrual cycle peaks of relaxin associated with matrix metalloproteinases (MMPs) activation and, hence, local collagen and gelatine degradation, but also, women have relaxin receptors in multiple joints, such that high relaxin levels correlate with greater joint laxity and a higher incidence of musculoskeletal injuries [15]. The inconsistency in findings between studies might result from varying measurement methods (e.g., validity of criterion outcome such as referring to tendon stiffness when joint laxity was assessed, measurement of serum vs. saliva hormone levels) and the timing of measurements (i.e., relative to menstrual cycle phase duration, which phases of the menstrual cycle have been contrasted, or whether sufficient delay has been allowed for any measurable hormonal impact).…”
Section: Introductionmentioning
confidence: 99%